Abstract 4489: N-Cadherin acts as a predictive biomarker for anti-FGFR therapy in <i>KRAS</i> wild-type NSCLC

Authors: Santiago G. Borrego, Cristina Cirauqui, David Gómez-Sánchez, Haiyun Wang, Alicia Luengo, Chiara Ambrogio, Luis Paz-Ares, Irene Ferrer

Published: 2023-04-05

DOI: 10.1158/1538-7445.am2023-4489

Source: Full article